Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
94.53
+5.83 (6.57%)
At close: Mar 11, 2026, 4:00 PM EDT
94.29
-0.24 (-0.25%)
After-hours: Mar 11, 2026, 4:10 PM EDT
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $263.34 million as of March 11, 2026. Its market cap has increased by 1,515.59% in one year.
Market Cap
263.34M
Enterprise Value
239.32M
1-Year Change
1,515.59%
Ranking
Category
Stock Price
$94.53
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has increased from $228.30M to $263.34M, an increase of 15.35%. That is a compound annual growth rate of 1.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 247.10M | 110.48% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cibus | 248.61M |
| Alector | 241.69M |
| Nuvectis Pharma | 240.54M |
| Cartesian Therapeutics | 234.55M |
| Protalix BioTherapeutics | 231.61M |
| Humacyte | 231.60M |
| Eledon Pharmaceuticals | 230.12M |
| Canton Strategic Holdings | 229.26M |